NCT07078292View on ClinicalTrials.gov

The Efficacy and Safety of First-line Treatment Combined With Immunotherapy for Advanced Hepatocellular Carcinoma: a Single Center, Real-world Study

Not yet recruitingOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

December 31, 2027

Conditions

Hepatocellular Carcinoma (HCC)Real World Study

All Listed Sponsors

lead

Tianjin Medical University Cancer Institute and Hospital

OTHER